Hormonal resistance in breast cancerJOHNSTON, S. R. D; ANDERSON, E; DOWSETT, M et al.Handbook of experimental pharmacology. 1999, Vol 135, pp 205-221, issn 0171-2004, 2Article

Management of metastatic melanoma during pregnancy. CommmentariesJOHNSTON, S. R. D; BROADLEY, K; HENSON, G et al.BMJ. British medical journal (International ed.). 1998, Vol 316, Num 7134, pp 848-851, issn 0959-8146Article

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-α) and interleukin (IL-2) in patients with metastatic melanomaJOHNSTON, S. R. D; CONSTENLA, D. O; MOORE, J et al.British journal of cancer. 1998, Vol 77, Num 8, pp 1280-1286, issn 0007-0920Article

Recurrent respiratory obstruction from a mediastinal bronchogenic cystJOHNSTON, S. R. D; ADAM, A; ALLISON, D. J et al.Thorax. 1992, Vol 47, Num 8, pp 660-662, issn 0040-6376Article

A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifenJOHNSTON, S. R. D; GUMBRELL, L. A; JONES, A et al.Cancer chemotherapy and pharmacology. 2004, Vol 53, Num 4, pp 341-348, issn 0344-5704, 8 p.Article

Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancerROSS, J. R; SAUNDERS, Y; EDMONDS, P. M et al.BMJ. British medical journal (International ed.). 2003, Vol 327, Num 7413, pp 469-472, issn 0959-8146, 4 p.Article

Continuous low dose Thalidomide : a phase II study in advanced melanoma, renal cell, ovarian and breast cancerEISEN, T; BOSHOFF, C; MAK, I et al.British journal of cancer. 2000, Vol 82, Num 4, pp 812-817, issn 0007-0920Article

Time-related effects of estrogen withdrawal on proliferation-and cell death-related events in MCF-7 xenograftsDETRE, S; SALTER, J; BARNES, D. M et al.International journal of cancer. 1999, Vol 81, Num 2, pp 309-313, issn 0020-7136Article

The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistanceJOHNSTON, S. R. D; RIDDLER, S; HAYNES, B. P et al.British journal of cancer. 1997, Vol 75, Num 6, pp 804-809, issn 0007-0920Article

Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancerDAFFACA, A. A. I; JOHNSTON, S. R. D; SMITH, I. E et al.Cancer research (Baltimore). 1995, Vol 55, Num 2, pp 288-293, issn 0008-5472Article

Positron emission tomography/computed tomography in the management of recurrent/metastatic breast cancer: a large retrospective study from the Royal Marsden HospitalCONSTANTINIDOU, A; MARTIN, A; SHARMA, B et al.Annals of oncology. 2011, Vol 22, Num 2, pp 307-314, issn 0923-7534, 8 p.Article

A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancerDE BOER, R. H; EISEN, T. G; ELLIS, P. A et al.Annals of oncology. 2002, Vol 13, Num 6, pp 889-894, issn 0923-7534Article

Caelyx®: phase II studies in ovarian cancerJOHNSTON, S. R. D; GORE, M. E.European journal of cancer. Supplement (1990). 2001, Vol 37, Num 9, pp S8-S14, issn 1359-6349Article

Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancerELLIS, P. A; SACCANI-JOTTI, G; ROBERTSON, J et al.International journal of cancer. 1997, Vol 72, Num 4, pp 608-613, issn 0020-7136Article

Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassaySACCANI JOTTI, G; JOHNSTON, S. R. D; SALTER, J et al.Journal of clinical pathology. 1994, Vol 47, Num 10, pp 900-905, issn 0021-9746Article

Elevated serum parathyroid hormone related protein and 1,25-dihydroxycholecalciferol in hypercalcaemia associated with adult T-cell leukaemia-lymphomaJOHNSTON, S. R. D; HAMMOND, P. J.Postgraduate medical journal. 1992, Vol 68, Num 803, pp 753-755, issn 0032-5473Article

Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancerURRUTICOECHEA, A; ARCHER, C. D; ASSERSOHN, L. A et al.British journal of cancer. 2005, Vol 92, Num 3, pp 475-479, issn 0007-0920, 5 p.Article

A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UKSMITH, D. H; ADAMS, J. R; JOHNSTON, S. R. D et al.Annals of oncology. 2002, Vol 13, Num 10, pp 1590-1597, issn 0923-7534, 8 p.Article

Oestrogen receptor mutants and variants in breast cancerDOWSETT, M; DAFFADA, A; CHAN, C. M. W et al.European journal of cancer (1990). 1997, Vol 33, Num 8, pp 1177-1183, issn 0959-8049Article

Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancerJOHNSTON, S. R. D; SACCANI-JOTTI, G; SMITH, I. E et al.Cancer research (Baltimore). 1995, Vol 55, Num 15, pp 3331-3338, issn 0008-5472Article

Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifenJOHNSTON, S. R. D; MACLENNAN, K. A; SACKS, N. P. M et al.European journal of cancer. Part A. 1994, Vol 30, Num 11, pp 1663-1669Article

Towards a molecular basis for tamoxifen resistance in breast cancerJOHNSTON, S. R. D; DOWSETT, M; SMITH, I. E et al.Annals of oncology. 1992, Vol 3, Num 7, pp 503-511, issn 0923-7534Article

A phase i dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancerGIBBS, D. D; PYLE, L; ALLEN, M et al.British journal of cancer. 2002, Vol 86, Num 9, pp 1379-1384, issn 0007-0920Article

Multimodality therapy in inflammatory breast cancer : Is there a place for surgery?DE BOER, R. H; ALLUM, W. H; EBBS, S. R et al.Annals of oncology. 2000, Vol 11, Num 9, pp 1147-1153, issn 0923-7534Article

Combining platinum, paclitaxel and anthracycline in patients with advanced gynaecological malignancyGREGORY, R. K; HILL, M. E; MOORE, J et al.European journal of cancer (1990). 2000, Vol 36, Num 4, pp 503-507, issn 0959-8049Article